Table 4 Patients studied – site of infection
Site of infection | Total no. of patients in this category | Number of patients suitable for switch to oral therapy (% of patients with this site of infection) | Number of patients suitable for switch to oral therapy and early discharge (% of patients with this site of infection) |
|---|---|---|---|
Blood | 40 | 8 (20%) | 3 (8%) |
Sputum | 40 | 2 (5%) | 2 (5%) |
Skin/Soft tissue | 118 | 77 (65%) | 54 (46%) |
Other | 13 | 6 (46%) | 3 (23%) |
Total | 211 | 93 | 62 |